CAS: 959860-85-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 3-Quinolinecarboxamide, 4-[(3,4-dimethylphenyl)amino]-7-(4-pyridinyl)- REF: IN-DA01FPPMCAS: 959860-85-6 | 98% | A consultar | Mar 29 Abr 25 |
 | cFMS Receptor Inhibitor II REF: 54-BUP04851CAS: 959860-85-6 | ≥98% | 388,00 €~815,00 € | Lun 28 Abr 25 |
 | cFMS Receptor Inhibitor II REF: TM-T5586CAS: 959860-85-6 | 99.80% | 49,00 €~547,00 € | Mar 06 May 25 |
 | cFMS Receptor Inhibitor II REF: 3D-JNB86085CAS: 959860-85-6 | Min. 95% | - - - | Producto descatalogado |
![3-Quinolinecarboxamide, 4-[(3,4-dimethylphenyl)amino]-7-(4-pyridinyl)-](https://static.cymitquimica.com/products/IN/thumb/DA01FPPM.jpg)
3-Quinolinecarboxamide, 4-[(3,4-dimethylphenyl)amino]-7-(4-pyridinyl)-
CAS:959860-85-6
Fórmula:
C23H20N4O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
368.4311
Ref: IN-DA01FPPM
| 1g | A consultar | ||
| 1mg | 61,00 € | ||
| 5mg | 204,00 € | ||
| 25mg | 159,00 € | ||
| 50mg | 268,00 € | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 29 de Abril de 2025
Ref: 54-BUP04851
| 25mg | 388,00 € | ||
| 50mg | 562,00 € | ||
| 100mg | 815,00 € |
Entrega estimada en Estados Unidos, el Lunes 28 de Abril de 2025
cFMS Receptor Inhibitor II
CAS:959860-85-6
cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor
Fórmula:
C23H20N4O
Pureza:
99.80%
Forma y color:
Solid
Peso molecular:
368.43
Ref: TM-T5586
| 1mg | 49,00 € | ||
| 2mg | 65,00 € | ||
| 5mg | 97,00 € | ||
| 10mg | 154,00 € | ||
| 25mg | 255,00 € | ||
| 50mg | 376,00 € | ||
| 100mg | 547,00 € | ||
| 1mL*10mM (DMSO) | 106,00 € |
Entrega estimada en Estados Unidos, el Martes 6 de Mayo de 2025
cFMS Receptor Inhibitor II
CAS:959860-85-6
cFMS Receptor Inhibitor II is a molecule that inhibits the transport chain by binding to …
Fórmula:
C23H20N4O
Pureza:
Min. 95%
Peso molecular:
368.43 g/mol
Ref: 3D-JNB86085
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
